Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function following T-cell depleted allogeneic

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The reactivity of Bw4+ HLA-B and HLA-A alleles with KIR3DL1: implications for patient and donor suitability for haploidentical stem cell transplantations.

  2008cited by this paper
• Cutting Edge: Viral Infection Breaks NK Cell Tolerance to “Missing Self”1

  2008cited by this paper
• MHC class I-specific inhibitory receptors and their ligands structure diverse human NK-cell repertoires toward a balance of missing self-response.

  2008cited by this paper
• An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation1

  2008cited by this paper
• Biology of Natural Killer Cells

  2008cited by this paper
• An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation.

  2008cited by this paper
• Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1.

  2008cited by this paper
• Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

  2008cited by this paper
• Impact of natural killer cell dose and donor killer‐cell immunoglobulin‐like receptor (KIR) genotype on outcome following human leucocyte antigen‐identical haematopoietic stem cell transplantation

  2007cited by this paper
• Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands

  2007cited by this paper
• Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

  2007cited by this paper
• Relevance of C1 and C2 Epitopes for Hemopoietic Stem Cell Transplantation: Role for Sequential Acquisition of HLA-C-Specific Inhibitory Killer Ig-Like Receptor1

  2007cited by this paper
• A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

  2007cited by this paper
• Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma

  2007cited by this paper
• KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.

  2006cited by this paper
• Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

  2006cited by this paper
• Human NK cell education by inhibitory receptors for MHC class I.

  2006cited by this paper
• Human natural killer cell development

  2006cited by this paper
• A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

  2005cited by this paper
• NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect.

  2005cited by this paper
• Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells

  2005cited by this paper
• KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation.

  2005cited by this paper
• Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias.

  2005cited by this paper
• Licensing of natural killer cells by host major histocompatibility complex class I molecules

  2005cited by this paper
• NK cell recognition.

  2005cited by this paper
• Multiple Cytokines Regulate the NK Gene Complex-Encoded Receptor Repertoire of Mature NK Cells and T Cells1

  2005cited by this paper
• Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

  2005cited by this paper
• Immediate Cytotoxicity But Not Degranulation Distinguishes Effector and Memory Subsets of CD8+ T Cells

  2004cited by this paper
• Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future

  2004cited by this paper
• Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation

  2003cited by this paper
• Ex vivo identification, isolation and analysis of tumor-cytolytic T cells

  2003cited by this paper
• Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.

  2003cited by this paper
• Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.

  2003cited by this paper
• Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants

  2002cited by this paper
• Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets1

  2002cited by this paper
• Ly49 and CD94/NKG2: developmentally regulated expression and evolution

  2001cited by this paper
• Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

  2001cited by this paper
• Human natural killer cells with polyclonal lectin and immunoglobulinlike receptors develop from single hematopoietic stem cells with preferential expression of NKG2A and KIR2DL2/L3/S2.

  2001cited by this paper
• The kinetics of circulating cytokines including IL-6, TNF-α, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation

  2001cited by this paper
• Regulation of immune responses through inhibitory receptors.

  1999cited by this paper
• Stable engraftment after megadose blood stem cell transplantation across the HLA barrier: the case for natural killer cells as graft-facilitating cells.

  1999cited by this paper
• Natural killer cells in antiviral defense: function and regulation by innate cytokines.

  1999cited by this paper
• Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

  1999cited by this paper
• Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.

  1999cited by this paper
• Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

  1998cited by this paper
• p46, a Novel Natural Killer Cell–specific Surface Molecule That Mediates Cell Activation

  1997cited by this paper
• Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice.

  1995cited by this paper
• Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells.

  1995cited by this paper
• In search of the 'missing self': MHC molecules and NK cell recognition.

  1990cited by this paper
• Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.

  1990cited by this paper

• CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells

  2014cites this paper
• Response by Activating Unlicensed NK Cells CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma

  2014cites this paper